Taylor Michael M

Show results for

Unknown (294)
Genomics (121)
Transcriptomics (41)
Proteomics (13)
Metabolomics (3)
Genomic (2)

Organisms

Homo sapiens (159)
Mus musculus (8)
Rattus norvegicus (2)
Toxoplasma gondii (1)
Corynebacterium glutamicum ATCC 13032 (1)
Drosophila melanogaster (1)
Danio rerio (1)
Halobacterium salinarum NRC-1 (1)
Medicago truncatula (1)

Organisms

Homo sapiens (1)

Repository

EGA (117)
biostudies-arrayexpress (45)
pride (10)
dbGaP (2)
MassIVE (2)
MetaboLights (2)
GNPS (1)
PeptideAtlas (1)
ENA (1)

Tissue

Cell culture (4)
Brain (2)
Epithelial cell (2)
Lung (2)
Permanent cell line cell (2)
Epithelial cell of lung (1)
Plant cell (1)
Root (1)

Disease

Mitochondrial complex I deficiency (2)
Non-small cell lung carcinoma (2)
Coronary artery disease (1)
Brain cancer (1)
Colon cancer (1)

Technology Type

Mass Spectrometry (10)
Illumina 15K (8)
Shotgun proteomics (8)
Affinity purification coupled with mass spectrometry proteomics (3)
Illumina HiSeq 2000, Illumina Genome Analyzer IIx (2)
NMR spectroscopy (2)
Affymetrix OncoScan FFPE Express (1)
Complete Genomics, unspecified (1)
Illumina Genome Analyzer IIx, Illumina HiSeq 2000 (1)
Illumina HiSeq 2000 (1)
Illumina HiSeq 2000, HumanMethylation450k Bead Chip - Genome Studio, Illumina Genome Analyzer IIx (1)
Illumina HiSeq 2000, Illumina Infinium HumanMethylation450 BeadChip, Affymetrix expression array, ILLUMINA (1)
Illumina HiSeq 2500 (ILLUMINA), AB SOLiD System (ABI_SOLID) (1)
Illumina OncoArray (1)
Mass spectrometry (1)
Bottom-up proteomics (1)
Data-dependent acquisition (1)

Instrument Platform

Orbitrap Fusion Lumos (2)
Q Exactive GC-MS Orbitrap (Thermo Scientific) (2)
Q Exactive HF (2)
DNA Microarray Scanner BA [Agilent Technologies] (1)
Illumina NovaSeq 6000 (1)
LTQ Orbitrap (1)
LTQ Orbitrap Velos (1)
Bruker (1)
Gas Chromatography MS - positive (1)
Nuclear Magnetic Resonance (NMR) - (1)
Unknown (1)

Publication Date

2015 (10)
2011 (8)
2012 (7)
2014 (6)
2010 (4)
2016 (3)
2021 (3)
2020 (3)
2022 (2)
2017 (2)
2013 (2)
2006 (2)
2004 (2)
2019 (2)
2024 (2)
2009 (1)
2008 (1)
2023 (1)

CHEBI ID

CHEBI:15428 (2)
CHEBI:16449 (2)
CHEBI:17234 (2)
CHEBI:18186 (2)
CHEBI:24898 (2)
CHEBI:25017 (2)
CHEBI:26271 (2)
CHEBI:26986 (2)
CHEBI:27266 (2)
CHEBI:28300 (2)
CHEBI:10642 (1)
CHEBI:1148 (1)
CHEBI:116314 (1)
CHEBI:131187 (1)
CHEBI:133637 (1)
CHEBI:1427 (1)
CHEBI:14314 (1)
CHEBI:14336 (1)
CHEBI:143581 (1)
CHEBI:144039 (1)
CHEBI:144042 (1)
CHEBI:144043 (1)
CHEBI:144044 (1)
CHEBI:144049 (1)
CHEBI:144050 (1)
CHEBI:144052 (1)
CHEBI:144053 (1)
CHEBI:15354 (1)
CHEBI:15356 (1)
CHEBI:15361 (1)

Metabolite Name

1-monolinolein (1)
11-trans-octadecenoic acid (1)
2,5-dihydroxypyrazine (1)
2-hydroxypyridine (1)
2-linoleoylglycerol (1)
2-palmitoylglycerol (1)
3,4-dihydroxybenzoic acid (1)
3-(3-hydroxyphenyl)propionic acid (1)
3-(4-hydroxyphenyl)propionic acid (1)
3-aminoisobutyric acid (1)
3-deoxyhexonic acid (1)
3-hydroxyisobutyric acid (1)
3-hydroxypyridine (1)
3-methylpiperazine-2,5-dione (1)
4-hydroxybenzoic acid (1)
4-hydroxyphenylacetic acid (1)
5-aminovaleric acid (1)
5-hydroxyindole-3-acetic acid (1)
5-hydroxyvaleric acid (1)
Acetate (1)
Alanine (1)
Aspartate (1)
D-fructose (1)
D-galactonic acid (1)
D-galactose (1)
D-gluconic acid (1)
D-glucose (1)
D-glucose-6-phosphate (1)
D-malic acid (1)
D-mannitol (1)

First Public Date

2015 (1)

Study type

Transcription profiling by array (22)
Methylation profiling by array (9)
Comparative genomic hybridization by array (6)
ChIP-seq (3)
Genotyping by array (2)
Other (1)
RNA-seq of coding RNA (1)

Release Date

2023 (39)
2022 (32)
2021 (32)
2024 (29)
2025 (26)
2018 (23)
2017 (22)
2015 (20)
2019 (19)
2012 (17)
2020 (15)
2016 (12)
2011 (12)
2014 (10)
2013 (8)
2010 (7)
2026 (6)
2009 (3)
2008 (3)
2006 (2)
2004 (2)

Lab affiliation

The Hospital for Sick Children (2)
Australian National University, ACT, Australia (1)
Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto (1)
Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Cancer Research Centre, Wilmslow Road, Manchester M20 4GJ, United Kingdom (1)
Molecular Genetics, University of Toronto Hospital for Sick Children, Toronto, Canada (1)
Neurosurgeon & Senior Scientist Developmental and Stem Cell Biology, The Hospital for Sick Children, Canada (1)
Program in Cell Biology Hospital For Sick Children, Toronto, SPARC BioCentre Hospital For Sick Children, Toronto, 8Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada (1)
Program in Cell Biology, SPARC BioCentre, Hospital For Sick Children, Toronto; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. (1)
Senior Lecturer, Wellcome Trust Centre for Cell-Matrix Research, Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Michael Smith Building, Oxford Road, Manchester M13 (1)

Tags

xref:PubMed:25957288 (1)

Previous page
1 / 48
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 48
Next page

Sort by:

Relevance

Page size

Transcription profiling of Drosophila mef2 allelic series reveals mef2 activity levels differentially affect gene expression during muscle development

The conserved Mef2 transcription factor is a major regulator of gene expression and differentiation. Recent genomic studies have identified a large number of mef2-regulated target genes with distinct temporal expression profiles during Drosophila myogenesis. However, the question remains as to how...

ORGANISM(S): Drosophila melanogaster

2008-06-17 | E-GEOD-9889 | biostudies-arrayexpress

Real-world study of the impact of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) on quality of life and productivity in Europe.

Not available

S-EPMC8310582 | biostudies-literature

Metal-catalyzed 1,2-shift of diverse migrating groups in allenyl systems as a new paradigm toward densely functionalized heterocycles.

Not available

S-EPMC3686647 | biostudies-literature

Spinal Ependymoma Gene Expression Data

Purpose: Myxopapillary ependymoma (MPE) is a distinct histological variant of ependymoma arising commonly in the spinal cord. Despite an overall favorable prognosis, distant metastases, subarachnoid dissemination, and late recurrences have been reported. Currently the only effective treatment for M...

ORGANISM(S): Homo sapiens

2015-09-02 | E-GEOD-66787 | biostudies-arrayexpress

Towards synthetic catechol rich protein analogues through tyrosinase catalyzed activation of a tyrosine dipeptide in continuous mode.

Not available

S-EPMC12573765 | biostudies-literature

Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR).

Not available

S-EPMC5455702 | biostudies-literature

Inactivating the spindle checkpoint kinase Bub1 during embryonic development results in a global shutdown of proliferation.

Not available

S-EPMC2754486 | biostudies-literature

Dual peptide nucleic acid- and peptide-functionalized shell cross-linked nanoparticles designed to target mRNA toward the diagnosis and treatment of acute lung injury.